Search Results - "GENCER BALABAN, Aynur"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Do children with solitary or hypofunctioning kidney have the same prevalence for masked hypertension? by Yel, Sibel, Günay, Neslihan, Pınarbaşı, Ayşe Seda, Balaban, Aynur Gencer, Caferoğlu, Zeynep, Dursun, İsmail, Poyrazoğlu, Muammer Hakan

    Published in Pediatric nephrology (Berlin, West) (01-07-2021)
    “…Background Having a low nephron number is a well-known risk factor for hypertension. There is an inverse relationship between the filtration surface area and…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Hemolytic Uremic Syndrome; 10 Year Single Center Experience by Sibel YEL, Neslihan GÜNAY, Hakan POYRAZOĞLU, Aynur GENCER BALABAN, İsmail DURSUN, Zübeyde GÜNDÜZ, Ruhan DÜŞÜNSEL

    Published in Kırşehir Ahi Evran medical journal (01-04-2022)
    “…Purpose: Hemolytic uremic syndrome (HUS) is a clinical syndrome characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury…”
    Get full text
    Journal Article
  7. 7

    Erythropoietin Resistance Index and the Affecting Factors in Children with Peritoneal Dialysis by Pınarbaşı, Ayşe Seda, Dursun, Ismail, Günay, Neslihan, Baatar, Batsaikhan, Yel, Sibel, Dursun, Jale, Balaban, Aynur Gencer, Poyrazoğlu, Muammer Hakan, Düşünsel, Ruhan

    Published in Blood purification (01-09-2021)
    “…Erythropoiesis-stimulating agents (ESAs) are used to treat anemia in CKD. Erythropoietin resistance index (ERI) is a useful tool used to evaluate the response…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Effects of Induction Steroid Dosing on Clinical Course in Childhood Nephrotic Syndrome/Cocukluk Cagi Nefrotik Sendromunda Induksiyon Steroid Dozunun Klinik Seyire Etkileri by Yel, Sibel, Gunay, Neslihan, Pinarbasi, Ayse Seda, Balaban, Aynur Gencer, Dursun, Ismail, Poyrazoglu, Muammer Hakan

    Published in Güncel pediatri (01-12-2020)
    “…INTRODUCTION: The optimum dose and duration of steroid therapy for childhood nephrotic syndrome (NS) is controversial. No benefit of increasing the duration of…”
    Get full text
    Journal Article